Angiotech eyes 2007.FDA for catheter
This article was originally published in Clinica
Executive Summary
Angiotech Pharmaceuticals intends to file a 510(k) submission with the US FDA for its anti-infective central venous catheter (CVC), 5-FU CVC, by the end of this year.